RAD · Radiopharm Theranostics Limited
0.003
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$23.55M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Franking
0%
MQV Rating
5Very Weak
As at 03/11/2026 04:10:13 PM
Price Chart
Description
- All-Companies
- All-Consensus
- Big Candle
- GROWTH AUS
- HALO Consensus Value
- HALO Earnings Momentum
- HALO Ords
- Near 52 Week Low
- Near Support
- Short Sold <-1 over the month
Key Fundamentals
EPS 3 yr Growth
-83.30%
EBITDA Margin
NaN%
Operating Cashflow
-$53m
Free Cash Flow Return
-151.90%
ROIC
-158.80%
Interest Coverage
-583.80
Quick Ratio
1.20
Performance
52 weeks range
Low 0 - 0.04
Trade Value (12mth)
AU$29,741.00
1 week
0%
1 month
-16.67%
YTD
-80%
1 year
-79.17%
All time high
0.45
Additional Data
Shares Outstanding (Fully Diluted)
3,544m
HALO Sector
Healthcare
Next Company Report Date
27-Aug-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Strong
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
30 October 26ASXD | |
27 October 26ASXD | |
26 October 26ASXD | |
20 October 26ASXD | |
20 October 26ASXD |
Key Stakeholders
| Name | Title |
| Lantheus Holdings, Inc. | Public Company |
| Kilinwata Investments Pty Ltd. | Private Company |
| Paul A. Hopper | Individual |
| Riccardo Canevari | Individual |
| Phillip Allen Hains | Individual |
